To explore the regulatory potential in trans of AFAP1-AS1 in lung cancer, we performed RNA antisense purification and mass spectrometry (RAP-MS) to characterize the proteins that bind directly to AFAP1-AS1 in vivo. Bound proteins were liberated from the RNA by treatment with RNase and identified by mass spectrometry. This evidence concerns the gene AFAP1 and lung cancer.